Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)
China
· Delayed Price · Currency is CNY 40.74
+1.34 (3.40%)
Apr 29, 2025, 3:04 PM CST
SHE:002294 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 601.57 | 580.07 | 637.09 | 533.73 | 60.86 | Upgrade
|
| Depreciation & Amortization | 374.33 | 345.61 | 320.16 | 304.27 | 246.03 | Upgrade
|
| Other Amortization | 35.82 | 29.83 | 28.87 | 20.16 | 17.92 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.15 | 0.48 | 0.18 | 1.3 | -0.21 | Upgrade
|
| Asset Writedown & Restructuring Costs | 159.64 | 52.5 | 50.67 | 131.6 | 284.31 | Upgrade
|
| Loss (Gain) From Sale of Investments | -47.95 | -20.21 | -44.14 | -134.24 | 26.78 | Upgrade
|
| Provision & Write-off of Bad Debts | 5.52 | 2.49 | 3 | 0.44 | -8.29 | Upgrade
|
| Other Operating Activities | 25.76 | 25.8 | 11.66 | 30.32 | 6.9 | Upgrade
|
| Change in Accounts Receivable | -57.58 | 3.96 | -89.42 | 69.97 | 613.44 | Upgrade
|
| Change in Inventory | -56.4 | 51.23 | -114.11 | -46.53 | 111.42 | Upgrade
|
| Change in Accounts Payable | 178.5 | -245.1 | 41.69 | 277.54 | 52.29 | Upgrade
|
| Change in Other Net Operating Assets | 22.8 | 25.91 | 104.38 | - | - | Upgrade
|
| Operating Cash Flow | 1,186 | 839.44 | 970.8 | 1,185 | 1,374 | Upgrade
|
| Operating Cash Flow Growth | 41.32% | -13.53% | -18.07% | -13.78% | -8.78% | Upgrade
|
| Capital Expenditures | -624.81 | -671 | -598.96 | -482.5 | -642.47 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.64 | 0.58 | 0.59 | 1.59 | 0.89 | Upgrade
|
| Investment in Securities | -946.99 | -730.75 | -682.06 | 93.53 | -225.04 | Upgrade
|
| Other Investing Activities | 45.61 | 30.35 | 7.12 | 17.73 | 17.17 | Upgrade
|
| Investing Cash Flow | -1,526 | -1,371 | -1,273 | -369.65 | -849.44 | Upgrade
|
| Short-Term Debt Issued | 119.3 | 223.73 | 596.83 | 303.9 | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 332 | Upgrade
|
| Total Debt Issued | 119.3 | 223.73 | 596.83 | 303.9 | 332 | Upgrade
|
| Short-Term Debt Repaid | -39.84 | -358.63 | -183.6 | -639.52 | - | Upgrade
|
| Long-Term Debt Repaid | -14.28 | -16.67 | -10.82 | -13.36 | -277.72 | Upgrade
|
| Total Debt Repaid | -54.12 | -375.3 | -194.42 | -652.87 | -277.72 | Upgrade
|
| Net Debt Issued (Repaid) | 65.18 | -151.56 | 402.41 | -348.97 | 54.28 | Upgrade
|
| Issuance of Common Stock | 602.02 | - | - | 2,331 | - | Upgrade
|
| Repurchase of Common Stock | - | - | -274.31 | -327.86 | -284.94 | Upgrade
|
| Common Dividends Paid | -546.04 | -549.37 | -441.2 | -15.54 | -534.82 | Upgrade
|
| Other Financing Activities | 0.68 | -4.57 | -88.41 | -90.45 | -1.38 | Upgrade
|
| Financing Cash Flow | 121.84 | -705.5 | -401.5 | 1,548 | -766.86 | Upgrade
|
| Foreign Exchange Rate Adjustments | 3.95 | 4.07 | 32.96 | -6.77 | -4.84 | Upgrade
|
| Net Cash Flow | -213.51 | -1,233 | -671.04 | 2,357 | -246.81 | Upgrade
|
| Free Cash Flow | 561.45 | 168.44 | 371.84 | 702.48 | 731.86 | Upgrade
|
| Free Cash Flow Growth | 233.31% | -54.70% | -47.07% | -4.01% | -30.26% | Upgrade
|
| Free Cash Flow Margin | 13.99% | 5.00% | 10.68% | 22.97% | 26.72% | Upgrade
|
| Free Cash Flow Per Share | 0.50 | 0.15 | 0.34 | 0.66 | 0.72 | Upgrade
|
| Cash Income Tax Paid | 455.26 | 406.42 | 404.25 | 324.11 | 295.41 | Upgrade
|
| Levered Free Cash Flow | 377.78 | -508.39 | 494.8 | 240.9 | 723.09 | Upgrade
|
| Unlevered Free Cash Flow | 387.89 | -497.53 | 502.64 | 247.48 | 734.07 | Upgrade
|
| Change in Net Working Capital | -152.29 | 579.5 | -399.08 | -90.37 | -921.15 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.